Skip to content

Optimizing the Prehospital Use of Stroke Systems of Care-Reacting to Changing Paradigms-Implementation (OPUS-i)

Optimizing the Prehospital Use of Stroke Systems of Care-Reacting to Changing Paradigms-Implementation (OPUS-i)

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06530693
Acronym
OPUS-i
Enrollment
360
Registered
2024-07-31
Start date
2025-04-01
Completion date
2027-09-01
Last updated
2026-03-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Brief summary

This interventional trial will compare a novel prehospital stroke transport algorithm (OPUS-i) to a traditional prehospital stroke transport algorithm to improve outcomes in rural stroke patients by determining the effect of implementing a data-driven prehospital stroke algorithm on time to and endovascular therapy. The study consists of a multicenter cohort and will last 24 months but individual subject study duration is 90 days.

Detailed description

Stroke is the fifth leading cause of death in the United States (U.S.) and causes one in six deaths from cardiovascular disease. Intravenous thrombolysis (IVT), unless contraindicated, is the standard of care for acute ischemic strokes (AIS) presenting within 4.5 hours of last known well. IVT plus endovascular therapy (EVT) is standard of care for the typically debilitating large vessel occlusion strokes (LVOS), which represent 30% of AIS. However, only a limited number of stroke centers provide EVT. Currently only 12% of all stroke patients are treated with IVT and only 8% of patients are treated with EVT. Therefore, optimizing prehospital systems of care to provide timely IVT and EVT to all patients. Most stroke patients arrive at the hospital by Emergency Medical Services (EMS). EMS clinicians use various stroke assessment tools to triage patients to the appropriate level of stroke center. Unfortunately, these prehospital stroke screen tools are imprecise and can delay care for LVOS patients. The choice of transport destination may vary by geography. In an urban area, where several stroke centers of varying capability may be concentrated in a small geographical area, there is negligible impact to the healthcare system if an ambulance bypasses the closest hospital for an ESC. In a more rural area, the decision regarding hospital transport destinations has greater implications. Transporting a patient to a farther ESC will result in a longer transport time and take an ambulance out of its primary coverage for a prolonged time. However, transporting rural stroke patients to their local non-ESC may worsen their clinical outcomes by delaying the time to EVT. Therefore, we propose to implement the novel OPUS-i prehospital stroke transport algorithm to improve outcomes for stroke patients.

Interventions

OTHEROPUS-i algorithm

A novel pre-hospital algorithm.

Sponsors

Temple University
Lead SponsorOTHER
Cooper University Health Care
CollaboratorOTHER
Geisinger Medical Center, Danville, PA
CollaboratorUNKNOWN
Thomas Jefferson University
CollaboratorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
SEQUENTIAL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Clinical impression of stroke/TIA by EMS clinicians

Exclusion criteria

* Age \< 18 years * Prisoner

Design outcomes

Primary

MeasureTime frameDescription
Time from stroke onset to endovascular therapyFrom time of stroke onset to endovascular therapy, assessed on day 0 of admissionThis outcome will assess process measures for acute stroke patients

Secondary

MeasureTime frameDescription
Time from stroke onset IVTFrom time of stroke onset to IVT, Assessed on day 0 of admissionThis outcome will assess process measures for acute stroke patients
Rate of bypass of non-ESCs for rural and urban patients.The percentage of patients bypassed from non-ESCs to ESCs, assessed on day 0 of admissionThis outcome will assess rates of bypass to narrow the disparity between urban and rural patients.
To evaluate the effect of a novel prehospital stroke transport algorithm on stroke outcomes in LVOSModified Rankin Scale of 0-2 at 90 days in patients with large vessel occlusion stroke.This outcome will assess good functional outcomes after stroke for the subgroup of LVOS patients
To evaluate the effect of a novel prehospital stroke transport algorithm on stroke outcomes in patients with LVOSModified Rankin Scale of 0-2 at 90 days for patients with intracranial hemorrhageThis outcome will assess good functional outcomes in patients with ICH.
To evaluate the effect of a novel prehospital stroke transport algorithm on stroke outcomes in patients with non-LVO AISModified Rankin Scale of 0-2 at 90 days for patients with non-LVO AISThis outcome will assess good functional outcomes in patients with non-LVO AIS
To evaluate the effect of a novel prehospital stroke transport algorithm on stroke outcomes in ICH.Modified Rankin Scale of 0-1 at 90 days for patients with intracranial hemorrhage.This outcome will assess excellent functional outcomes after ICH.
To evaluate the effect of a novel prehospital stroke transport algorithm on stroke outcomes in non-LVO AIS.Modified Rankin Scale of 0-1 at 90 days for patients with non-LVO AISThis outcome will assess excellent functional outcomes after non-LVO AIS.
To evaluate the effect of a novel prehospital stroke transport algorithm on stroke outcomesup to 90 daysThis will assess good functional outcomes after stroke.
To evaluate the effect of a novel prehospital stroke transport algorithm on stroke outcomes in LVOS.up to 90 daysThis outcome will assess excellent functional outcomes after stroke in patients with LVOS.
To evaluate the effect of a novel prehospital stroke transport algorithm on stroke outcomes in ICHup to 90 daysThis outcome will assess excellent functional outcomes after ICH.
To evaluate the effect of a novel prehospital stroke transport algorithm on stroke outcomes in non-LVO AISup to 90 daysThis outcome will assess excellent functional outcomes after non-LVO AIS.
To evaluate the effect of a novel prehospital stroke transport algorithm on patients with hyperacute strokes To evaluate the effect of a novel prehospital stroke transport algorithm on patients with hyperacute strokesModified Rankin Scale of 0-2 at 90 days in patients with last known well to hospital arrival of <4 hourThis outcome will assess good functional outcomes after hyperacute ischemic stroke.
To evaluate the effect of a novel prehospital stroke transport algorithm on all-cause mortalityAll-cause mortality at 90 daysThis outcome will assess all-cause mortality at 90 days.
To evaluate the effect of a novel prehospital stroke transport algorithm on all-cause mortality in LVOS patientsAll-cause mortality at 90 days for LVOS patientsThis outcome will assess all-cause mortality at 90 days for LVOS patients.
To evaluate the effect of a novel prehospital stroke transport algorithm on all-cause mortality in patients with ICHAll-cause mortality at 90 days for patients with ICHThis outcome will assess all-cause mortality at 90 days for patients with ICH.
To evaluate the effect of a novel prehospital stroke transport algorithm on all-cause mortality for patients with non-LVO AISAll-cause mortality at 90 days for patients with non-LVO AISThis outcome will assess all-cause mortality at 90 days for patients with non-LVO AIS.
To evaluate process measures in stroke careup to 90 daysThis outcome will assess the effect of the OPUS-i algorithm on time from stroke onset to IVT
To evaluate the effect of a novel prehospital stroke transport algorithm on stroke outcomes.Modified Rankin Scale of 0-1 at 90 days for all patients.This outcome will assess excellent functional outcome after stroke.
To compare the above processes and outcomes in rural versus urban patientsup to 90 daysmRS in rural vs urban patients

Countries

United States

Contacts

CONTACTDerek Isenberg, MD
derek.isenberg@tuhs.temple.edu2157077550
PRINCIPAL_INVESTIGATORDerek Isenberg, MD

Lewis Katz School of Medicine at Temple University

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 13, 2026